DRACEN PHARMACEUTICALS

Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients and potentially extend the benefits of immuno-oncology therapies. The company develops novel glutamine antagonists with direct anti-tumor apoptotoc properties as well as endogenous anti-tumor immune modulatory mechanisms which increases the number of responders to anti-cancer therapy and extend survival for anti-tumor responses in areas currently evading immuno-oncology approaches.

#People #Financial #Website #More

DRACEN PHARMACEUTICALS

Social Links:

Linkedin

Industry:

Health Care Pharmaceutical

Founded:

2016-01-01

Address:

Baltimore, Maryland, United States

Country:

United States

Website Url:

http://www.dracenpharma.com

Total Employee:

251+

Status:

Active

Contact:

(917) 398-3710

Email Addresses:

[email protected]

Total Funding:

48.58 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Font Awesome Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online Organization Schema

Current Employees Featured

tom-estok_image

Tom Estok
Tom Estok President & CEO, Director @ Dracen Pharmaceuticals
President & CEO, Director
2017-05-01

Founder

tom-estok_image

Tom Estok

Investors List

i-i-prague_image

i&i Prague

i&i Prague investment in Series A - Dracen Pharmaceuticals

deerfield_image

Deerfield

Deerfield investment in Series A - Dracen Pharmaceuticals

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Series A - Dracen Pharmaceuticals

Official Site Inspections

http://www.dracenpharma.com Semrush global rank: 5.8 M Semrush visits lastest month: 1.44 K

Host Informations
Whois Informations

Loading ...

More informations about "Dracen Pharmaceuticals" on Search Engine